These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Treatment of familial dysautonomia with bethanecol. Hochberg Z J Pediatr; 1976 Nov; 89(5):862-3. PubMed ID: 978345 [No Abstract] [Full Text] [Related]
27. DNA polymorphisms for the nerve growth factor receptor gene exclude its role in familial dysautonomia. Breakefield XO; Ozelius L; Bothwell MA; Chao MV; Axelrod F; Kramer PL; Kidd KK; Lanahan AA; Johnson DE; Ross AH Mol Biol Med; 1986 Dec; 3(6):483-94. PubMed ID: 2886891 [TBL] [Abstract][Full Text] [Related]
28. Clinical evaluation of the dental aspects of familial dysautonomia: a preliminary report. Reitman AA; Blacharsh C; Levy JM J Am Dent Assoc; 1965 Dec; 71(6):1436-46. PubMed ID: 4378742 [No Abstract] [Full Text] [Related]
29. [Nerve growth factor auto-antibodies in the sera of mothers of schizophrenic children and children from high risk group]. Zakharenko OM; Kliushnik TP; Kozlova IA; Kozlovskaia GV; Danilovskaia EV; Bashina VM; Simashkova VM; Goriunova AV; Kalinina MA Zh Nevrol Psikhiatr Im S S Korsakova; 1999; 99(3):44-6. PubMed ID: 10205843 [TBL] [Abstract][Full Text] [Related]
30. [Possibilities of a familial factor in the pathogenesis of neurovegetative seizures]. Fois A; Borgheresi S; Luti E Riv Clin Pediatr; 1967 Feb; 79(2):72-82. PubMed ID: 5601262 [No Abstract] [Full Text] [Related]
31. Salt conservation in familial dysautonomia (Riley-Day syndrome). Landau H; Friedman J; Rösler A; Moses SW; Freier TS; Rotem Y; Rabinowitz D Isr J Med Sci; 1977 Mar; 13(3):278-82. PubMed ID: 856765 [TBL] [Abstract][Full Text] [Related]
32. Riley-Day syndrome (familial dysautonomia). Survey of 27 cases. Goldstein-Nieviazhski C; Wallis K Ann Paediatr; 1966; 206(3):188-94. PubMed ID: 5953423 [No Abstract] [Full Text] [Related]
33. Progressive sensory loss in familial dysautonomia. Axelrod FB; Iyer K; Fish I; Pearson J; Sein ME; Spielholz N Pediatrics; 1981 Apr; 67(4):517-22. PubMed ID: 7254974 [TBL] [Abstract][Full Text] [Related]
34. Milk antibodies in familial dysautonomia. Drucker MM; Russell A Pediatrics; 1969 Aug; 44(2):265-8. PubMed ID: 4979869 [No Abstract] [Full Text] [Related]
35. Behavioral effects of early deprivation of nerve growth factor: some similarities with familial dysautonomia. Bell J; Gruenthal M; Finger S; Lundberg P; Johnson E Brain Res; 1982 Feb; 234(2):409-21. PubMed ID: 7059836 [TBL] [Abstract][Full Text] [Related]
38. Excretion of catecholamine metabolites by children with familial dysautonomia. Gitlow SE; Bertani LM; Wilk E; Li BL; Dziedzic S Pediatrics; 1970 Oct; 46(4):513-22. PubMed ID: 5503687 [No Abstract] [Full Text] [Related]
39. Familial dysautonomia. A report of genetic and clinical studies, with a review of the literature. Brunt PW; McKusick VA Medicine (Baltimore); 1970 Sep; 49(5):343-74. PubMed ID: 4322121 [No Abstract] [Full Text] [Related]
40. Nerves in the skin of a patient with familial dysautonomia (Riley-Day Syndrome). Winkelmann RK; Bourlond A; Smith AA Pediatrics; 1966 Dec; 38(6):1060-2. PubMed ID: 5928722 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]